The pathogenesis of systemic sclerosis

被引:0
作者
Huber, LC [1 ]
Distler, JHW [1 ]
Gay, S [1 ]
Distler, O [1 ]
机构
[1] Univ Spital Zurich, WHO, Collaborating Ctr Mol Biol & Novel Therapeut Stra, Zentrum Expt Rheumatol, Zurich, Switzerland
关键词
systemic sclerosis; fibrosis; angiogeneris; autoantibodies; cellular immunity; regulation of collagen genes;
D O I
10.1055/s-2005-858834
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic sclerosis (SSc) is an uncommon, complex, multisystemic disorder, characterized by severe fibrosis of the skin and various internal organs. As in other collagenoses, the etiology of SSc is unknown and the exact mechanisms involved in the pathogenesis are not well understood. For the clinical and pathogenetic manifestations, however, the following key processes have been identified: 1) excessive accumulation of collagen and other components of the extracellular matrix; 2) early morphological changes in small blood vessels; and 3) alterations in the cellular and humoral immune response resulting in the production of disease-specific antibodies. Currently, it remains unclear how these processes interact, to cause a chronic and progressive fibrotic disease. Continued research, has however yielded substantial insight into the molecular understanding of several basic mechanisms, suggesting novel therapeutic targets for the future.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 95 条
  • [71] DEMONSTRATION OF INTERLEUKIN-8 AND AUTOANTIBODIES TO INTERLEUKIN-8 IN THE SERUM OF PATIENTS WITH SYSTEMIC-SCLEROSIS AND RELATED DISORDERS
    REITAMO, S
    REMITZ, A
    VARGA, J
    CESKA, M
    EFFENBERGER, F
    JIMENEZ, S
    UITTO, J
    [J]. ARCHIVES OF DERMATOLOGY, 1993, 129 (02) : 189 - 193
  • [72] Evidence-based guidelines for the use of immunologic tests: Anticentromere, Scl-70, and nucleolar antibodies
    Reveille, JD
    Solomon, DH
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (03): : 399 - 412
  • [73] Reveille John D., 1995, Current Opinion in Rheumatology, V7, P522, DOI 10.1097/00002281-199511000-00010
  • [74] LYMPHOCYTES IN THE SKIN OF PATIENTS WITH PROGRESSIVE SYSTEMIC-SCLEROSIS - QUANTIFICATION, SUBTYPING, AND CLINICAL CORRELATIONS
    ROUMM, AD
    WHITESIDE, TL
    MEDSGER, TA
    RODNAN, GP
    [J]. ARTHRITIS AND RHEUMATISM, 1984, 27 (06): : 645 - 653
  • [75] Saitta B, 2000, ARTHRITIS RHEUM-US, V43, P2219, DOI 10.1002/1529-0131(200010)43:10<2219::AID-ANR9>3.0.CO
  • [76] 2-N
  • [77] Is systemic sclerosis an antigen-driven T cell disease?
    Sakkas, LI
    Platsoucas, CD
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (06): : 1721 - 1733
  • [78] Oligoclonal T cell expansion in the skin of patients with systemic sclerosis
    Sakkas, LI
    Xu, B
    Artlett, CM
    Lu, S
    Jimenez, SA
    Platsoucas, CD
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (07) : 3649 - 3659
  • [79] Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression
    Salcedo, R
    Ponce, ML
    Young, HA
    Wasserman, K
    Ward, JM
    Kleinman, HK
    Oppenheim, JJ
    Murphy, WJ
    [J]. BLOOD, 2000, 96 (01) : 34 - 40
  • [80] Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis
    Sawaya, HHB
    Jimenez, SA
    Artlett, CM
    [J]. RHEUMATOLOGY, 2004, 43 (08) : 965 - 968